Advertisement

The relevance of ANXA5 genetic variants on male fertility

  • Heloisa Lopes Lavorato
  • Arseni Markoff
  • Valeria Altholz
  • Nadja Bogdanova
  • Peter Wieacker
  • Sabine Kliesch
  • Stefan SchlattEmail author
Genetics

Abstract

Purpose

To investigate the effect of the anticoagulation factor annexin A5 on male fertility and to provide perspective on the influence of members of the coagulation cascade on fertility.

Methods

Patients with normozoospermia and with unexplained severe oligozoospermia were retrospectively selected and their genomic DNA sequenced for the promoter region of ANXA5. The genotypes proportions and the odds ratio for carriership of the haplotype M2 were compared between the groups and population control. The clinical data used were gathered from parameters determined during routine clinical assessment and were compared between carriers and non-carriers within the patient groups.

Results

The carrier rates for the haplotype M2/ANXA5 were of 25.73%, 20.81%, and 15.3% in the severe oligozoospermic, the normozoospermic, and the general population control groups, respectively. The OR between patients groups was of 1.31 (95% CI 0.88 to 1.96 p = 0.176). Oligozoospermic and normozoospermic patients compared with the control group had an OR of 1.9 (95% CI 1.33 to 2.73 p < 0.001) and 1.45 (95% CI 0.99 to 2.10 p = 0.054) respectively. The clinical parameters that differed between the carriers and non-carriers of the haplotype M2/ANXA5 were prolactin, α-glucosidase, and fructose. The differences were only statistically significant in the normozoospermic group.

Conclusions

Athough the infertile patient groups had a higher prevalence of promoter variants, we could not demonstrate any biologically relevant effect of lower levels of annexin A5 on most male fertility parameters. A deficiency in an anticoagulation factor does not seem to impact male fertility.

Keywords

Annexin A5 Male fertility Haplotype M2 ANXA5 Sperm count Coagulation cascade 

Notes

Acknowledgments

The authors thank Michelina Kierzek for language editing the manuscript and Albrecht Röpke for the laboratory work.

Funding information

Full doctorate fellowship for Heloisa Lopes Lavorato was provided by the Brazilian program Science without Borders by the Brazilian funding agency Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) under the process 206742/2014-2. A STIBET-DAAD fellowship was awarded to HL by the University Münster. Experimental work was supported by the DFG Clinical Research Unit 326.

References

  1. 1.
    Simcox LE, Ormesher L, Tower C, Greer IA. Thrombophilia and pregnancy complications. Int J Mol Sci. 2015;16:28418–28.CrossRefGoogle Scholar
  2. 2.
    Cohn DM, Repping S, Büller HR, Meijers JCM, Middeldorp S. Increased sperm count may account for high population frequency of factor V Leiden. J Thromb Haemost [Internet]. 2010;8:513–6.  https://doi.org/10.1111/j.1538-7836.2009.03710.x.CrossRefGoogle Scholar
  3. 3.
    Yapijakis C, Pachis N, Avgoustidis D, Adamopoulou M, Serefoglou Z. Mutations of two major coagulation factors are not associated with male infertility. In Vivo (Brooklyn) [Internet]. 2016;30:927–30.  https://doi.org/10.21873/invivo.11015.
  4. 4.
    Bogdanova N, Horst J, Chlystun M, Croucher PJP, Nebel A, Bohring A, et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet [Internet]. 2007;16:573–8.  https://doi.org/10.1093/hmg/ddm017.CrossRefGoogle Scholar
  5. 5.
    Markoff A, Gerdes S, Feldner S, Bogdanova N, Gerke V, Grandone E. Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele. Placenta [Internet]. 2010;31:937–40. Elsevier Ltd.  https://doi.org/10.1016/j.placenta.2010.08.002.CrossRefGoogle Scholar
  6. 6.
    Chinni E, Tiscia GL, Colaizzo D, Vergura P, Margaglione M, Grandone E.. Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. Fertil Steril [Internet]. 2009;[cited 2015 Jul 3];91:940–2.  https://doi.org/10.1016/j.fertnstert.2007.12.056.
  7. 7.
    Tüttelmann F, Ivanov P, Dietzel C, Sofroniou A, Tsvyatkovska TM, Komsa-Penkova RS, et al. Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk. Fertil Steril [Internet]. 2013;100:1321–5.  https://doi.org/10.1016/j.fertnstert.2013.06.046.
  8. 8.
    Rogenhofer N, Engels L, Bogdanova N, Tüttelmann F, Markoff A, Thaler C. Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study. Fertil Steril [Internet]. 2012;98:383–8.  https://doi.org/10.1016/j.fertnstert.2012.04.026.
  9. 9.
    Demetriou C, Abu-amero S, White S, Peskett E, Markoff A, Stanier P, et al. Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion. Reprod Biomed Online [Internet]. 2015;31:681–8.  https://doi.org/10.1016/j.rbmo.2015.07.004.
  10. 10.
    Li J, Liu F, Liu X, Liu J, Zhu P, Wan F, et al. Mapping of the human testicular proteome and its relationship with that of the epididymis and spermatozoa. Mol Cell Proteomics [Internet]. 2011;10:M110.004630–0.  https://doi.org/10.1074/mcp.M110.004630.
  11. 11.
    Guyonnet B, Dacheux F, Dacheux J-L, Gatti J-L. The Epididymal transcriptome and proteome provide some insights into new epididymal regulations. J Androl [Internet]. 2011;32:651–64.  https://doi.org/10.2164/jandrol.111.013086.CrossRefGoogle Scholar
  12. 12.
    Haigler HT, Christmas P. Annexin 1 is secreted by the human prostate. Biochem Soc Trans [Internet]. 1990 [cited 2016 Aug 25];18:1104–6. Available from:  https://doi.org/10.1042/bst0181104.
  13. 13.
    Amaral A, Castillo J, Ramalho-Santos J, Oliva R. The combined human sperm proteome: cellular pathways and implications for basic and clinical science. Hum Reprod Update [Internet]. 2014;20:40–62.  https://doi.org/10.1093/humupd/dmt046.CrossRefGoogle Scholar
  14. 14.
    Giambanco I, Pula G, Ceccarelli P, Bianchi R, Donato R. Immunohistochemical localization of annexin V (CaBP33) in rat organs. J Histochem Cytochem [Internet]. 1991;39:1189–98.  https://doi.org/10.1177/39.9.1833446.CrossRefGoogle Scholar
  15. 15.
    Kawaminami M, Kawamoto T, Tanabe T, Yamaguchi K, Mutoh K, Kurusu S, et al. Immunocytochemical localization of annexin 5, a calcium-dependent phospholipid-binding protein, in rat endocrine organs. Cell Tissue Res [Internet]. 1998 [cited 2015 Jul 3];292:85;292:85.  https://doi.org/10.1007/s004410051037.CrossRefGoogle Scholar
  16. 16.
    Arruda J, Viana Neto A, Souza C, Martins J, Moreno FB, Moreira ACO, et al. Major proteins of the seminal plasma of New Zealand White rabbits and association with semen criteria. 10th World Rabbit Congr World Rabbit Sci Assoc [Internet]. 2012;82:395–9 Available from: https://world-rabbit-science.com/WRSA-Proceedings/Congress-2012-Egypt/Papers/02-Reproduction/R-Arruda-Alencar.pdf.Google Scholar
  17. 17.
    WHO. WHO laboratory manual for the examination and processing of human semen. Edition, V. 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241547789_eng.pdf
  18. 18.
    Krawczak M, Nikolaus S, von Eberstein H, Croucher PJP, El Mokhtari NE, PopGen SS. Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 2006;9:55–61.  https://doi.org/10.1159/000090694.
  19. 19.
    Rogenhofer N, Markoff A, Wagner A, Klein H-G, Petroff D, Schleussner E, et al. Lessons from the EThIGII trial. Clin Appl Thromb [Internet]. 2017;23:27–33.  https://doi.org/10.1177/1076029616658117.CrossRefGoogle Scholar
  20. 20.
    Rousset F. genepop’007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resour [Internet]. 2008;8:103–6.  https://doi.org/10.1111/j.1471-8286.2007.01931.x.CrossRefGoogle Scholar
  21. 21.
    Cooper TG. Secretory proteins from the epididymis and their clinical relevance. Andrologia [Internet]. 1990;22(Suppl 1):155–65 Available from: 2132067.Google Scholar
  22. 22.
    Kawaminami M, Tanaka K, Asawa T, Osugi S, Kawauchi ’ H, Kurusu S, et al. Association of annexin V with prolactin in the rat anterior pituitary gland. Biochem Biophys Res Commun. 1992;186:894–9.CrossRefGoogle Scholar
  23. 23.
    Kawaminami M, Okazaki K, Uchida S, Marumoto N, Takehara K, Kurusu S, et al. Intrapituitary distribution and effects of annexin 5 on prolactin release. Endocrine. 1996;5:9–14.CrossRefGoogle Scholar
  24. 24.
    Kawaminami M, Shibata Y, Yaji A, Kurusu S, Hashimoto I. Prolactin inhibits annexin 5 expression and apoptosis in the Corpus luteum of pseudopregnant rats: involvement of local gonadotropin-releasing hormone. Endocrinology [Internet]. 2003;144:3625–31.  https://doi.org/10.1210/en.2003-0118.CrossRefGoogle Scholar
  25. 25.
    Kawaminami M, Senda A, Etoh S, Miyaoka H, Kurusu S, Hashimoto I. Annexin 5 inhibits thyrotropin releasing hormone (TRH) stimulated prolactin release in the primary culture of rat anterior pituitary cells. Endocr J. 2004;51:349–54.CrossRefGoogle Scholar
  26. 26.
    Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Rev Endocr Metab Disord [Internet]. 2015;16:233–48.  https://doi.org/10.1007/s11154-015-9322-3.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Heloisa Lopes Lavorato
    • 1
  • Arseni Markoff
    • 2
  • Valeria Altholz
    • 2
  • Nadja Bogdanova
    • 2
  • Peter Wieacker
    • 2
  • Sabine Kliesch
    • 1
  • Stefan Schlatt
    • 1
    Email author
  1. 1.Centre of Reproductive Medicine and AndrologyUniversity of MünsterMünsterGermany
  2. 2.Institute of Human GeneticsUniversity of MünsterMünsterGermany

Personalised recommendations